ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
3,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
5,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
6,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
6,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
7,1,Hyperkinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
7,2,Intellectual disability,Intellectual disabilities,Mental impairment disorders,Nerv,N
7,3,Jaundice neonatal,Neonatal hepatobiliary disorders,Neonatal and perinatal conditions,Preg,N
7,4,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
8,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
9,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
10,1,Goitre,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
11,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
11,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
12,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
13,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
14,1,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
15,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
15,2,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
16,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
17,1,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
17,2,Limb reduction defect,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
18,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
18,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
19,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
19,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
19,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
19,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
20,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
20,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
20,3,Migraine,Migraine headaches,Headaches,Nerv,N
21,1,Acute generalised exanthematous pustulosis,Pustular conditions,Epidermal and dermal conditions,Skin,N
22,1,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
23,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
23,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
23,3,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
23,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
24,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
24,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
24,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
24,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
24,5,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
24,6,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
24,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
24,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
25,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
25,2,Creatinine renal clearance decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
26,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
27,1,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
27,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
27,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
28,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
28,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
28,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
29,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
29,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
29,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
30,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
30,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
30,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
31,1,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
32,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
33,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
33,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
33,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
34,1,Panniculitis,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
35,1,Coronary artery disease,Coronary artery disorders NEC,Coronary artery disorders,Card,Y
36,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
37,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
37,2,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,Y
38,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
39,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
39,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
40,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
40,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
41,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
42,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
42,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
43,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
44,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
44,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
45,1,Ejaculation failure,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
45,2,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
45,3,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
46,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
47,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
47,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
48,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
49,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
49,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
49,3,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
49,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
49,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
50,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
51,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
51,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
52,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
53,1,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
54,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
55,1,Vasculitis necrotising,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
56,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
57,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
57,2,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
57,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
58,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
59,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
59,2,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
60,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
61,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
62,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
63,1,Capillaritis,Skin vasculitides,Skin vascular abnormalities,Skin,N
64,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
64,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
64,3,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
65,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
66,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
67,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
67,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
68,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
68,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
68,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
68,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
69,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
69,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
69,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
70,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
70,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
70,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
70,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
71,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
71,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
71,3,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
72,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
73,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
73,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
73,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
74,1,Anterior chamber disorder,"Anterior chamber structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
74,2,Conjunctival hyperaemia,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
74,3,Iris adhesions,"Iris and ciliary body structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
74,4,Keratic precipitates,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
74,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
74,6,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
74,7,Vitritis,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
75,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
75,2,Toxic skin eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
76,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
77,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
78,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
78,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
79,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
80,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
81,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
81,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
81,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
81,4,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
82,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
82,2,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
82,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
82,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
82,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
83,1,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
83,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
84,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
85,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
86,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
86,2,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
86,3,Ovarian failure,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
87,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
87,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
87,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
88,1,Headache,Headaches NEC,Headaches,Nerv,N
88,2,Visual field defect,Visual field disorders,Vision disorders,Eye,N
88,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
89,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
89,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
89,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
89,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
89,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
90,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
90,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
91,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
92,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
92,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
92,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
92,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
92,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
93,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
94,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
94,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
94,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
95,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
95,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
96,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
96,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
96,3,Peptic ulcer perforation,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
96,4,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
97,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
97,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
97,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
98,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
98,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
99,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
100,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
100,2,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
101,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
101,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
101,3,Blood creatine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
101,4,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
101,5,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
101,6,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
102,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
102,2,Acanthosis,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
102,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
102,4,Epidermal necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
102,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
102,6,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
102,7,Hyperkeratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
102,8,Inflammation,Inflammations,General system disorders NEC,Genrl,N
102,9,Lichen planus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
102,10,Lymphocytic infiltration,Leukocytoses NEC,White blood cell disorders,Blood,N
102,11,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
102,12,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
102,13,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
102,14,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
102,15,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
102,16,Skin oedema,Skin vascular conditions NEC,Skin vascular abnormalities,Skin,N
102,17,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
102,18,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
103,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
104,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
105,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
106,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
106,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
106,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
107,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
108,1,Brain scan abnormal,Central nervous system imaging procedures,"Neurological, special senses and psychiatric investigations",Inv,N
108,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
108,3,Hyporeflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
108,4,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
108,5,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
109,1,Motion sickness,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
109,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
109,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
110,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
110,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
111,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
112,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
113,1,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
113,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
113,3,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
113,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
113,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
114,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
114,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
114,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
114,4,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
114,5,Tendinous contracture,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
115,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
115,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
115,3,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
116,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
117,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
118,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
118,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
119,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
119,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
119,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
119,4,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
119,5,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
119,6,Lymphocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
119,7,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
119,8,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
119,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
120,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
120,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
121,1,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
121,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
121,3,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
121,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
122,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
123,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
123,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
123,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
123,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
123,5,Headache,Headaches NEC,Headaches,Nerv,N
123,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
123,7,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
124,1,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
125,1,Radiculitis brachial,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
126,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
127,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
128,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
128,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
128,3,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
129,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
129,2,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
130,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
130,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
131,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
131,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
132,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
133,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
134,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
135,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
136,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
137,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
138,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
139,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
140,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
141,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
142,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
143,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
144,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
145,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
146,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
147,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
148,1,Human chorionic gonadotropin increased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
149,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
150,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
151,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
152,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
153,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
154,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
155,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
156,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
157,1,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
158,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
158,2,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
158,3,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
158,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
158,5,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
159,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
160,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
161,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
161,2,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
161,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
161,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
161,5,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
162,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
162,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
162,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
162,4,Slow response to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
163,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
164,1,Sinus node dysfunction,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
165,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
166,1,Cerebral disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
166,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
166,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
167,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
167,2,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
168,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
168,2,Antinuclear antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
168,3,Aspiration bone marrow abnormal,Bone marrow and immune tissue histopathology procedures,Haematology investigations (incl blood groups),Inv,N
168,4,Fibrosis,Fibrosis NEC,Tissue disorders NEC,Genrl,N
168,5,Microangiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
168,6,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
168,7,Myelofibrosis,Myeloproliferative disorders (excl leukaemias),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
168,8,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
168,9,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
168,10,Platelet count abnormal,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
168,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
168,12,Red blood cell abnormality,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
168,13,Rheumatoid factor positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
168,14,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
169,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
169,2,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
170,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
171,1,Anaemia macrocytic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
171,2,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
172,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
173,1,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
174,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
174,2,International normalised ratio decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
174,3,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
175,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
175,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
175,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
175,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
176,1,Arteriospasm coronary,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
176,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
177,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
177,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
177,3,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
177,4,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
178,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
178,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
178,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
179,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
179,2,Cerebral toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,Y
179,3,Citrobacter sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
179,4,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
179,5,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
179,6,Molluscum contagiosum,Molluscum contagiosum viral infections,Viral infectious disorders,Infec,N
179,7,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
179,8,Pseudomonal sepsis,Pseudomonal infections,Bacterial infectious disorders,Infec,N
179,9,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
180,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
181,1,Ophthalmoplegia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
182,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
183,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
183,2,Neuromyopathy,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
184,1,Arteriospasm coronary,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
184,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
184,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
184,4,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
185,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
186,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
186,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
187,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
187,2,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
187,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
187,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
188,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
189,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
190,1,Fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
190,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
191,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
192,1,Phrenic nerve paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
193,1,Large intestinal ulcer,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
193,2,Necrotising colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
193,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
193,4,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
193,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
193,6,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
193,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
194,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
194,2,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
194,3,Traumatic lung injury,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
195,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
195,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
195,3,Blood alkaline phosphatase abnormal,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
195,4,Blood bilirubin abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
195,5,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
195,6,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
195,7,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
195,8,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
195,9,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
195,10,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
195,11,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
195,12,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
195,13,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
195,14,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
195,15,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
195,16,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
195,17,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
195,18,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
195,19,Transaminases abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
195,20,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
196,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
196,2,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
196,3,Salmonellosis,Salmonella infections,Bacterial infectious disorders,Infec,N
197,1,Exposure via body fluid,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
198,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
198,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
198,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
198,4,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
199,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
199,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
199,3,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
200,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
200,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
200,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
201,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
202,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
203,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
204,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
205,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
206,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
207,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
208,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
209,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
210,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
211,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
212,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
213,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
214,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
214,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
214,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
214,4,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
215,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
216,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
217,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
218,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
219,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
219,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
220,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
221,1,Follicular mucinosis,Alopecias,Skin appendage conditions,Skin,N
221,2,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
222,1,Azotaemia,Renal failure complications,Renal disorders (excl nephropathies),Renal,N
222,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
222,3,Hyperammonaemic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
223,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
224,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
225,1,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
225,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
226,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
226,2,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
226,3,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
227,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
227,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
227,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
227,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
227,5,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
227,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
228,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
229,1,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
229,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
230,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
231,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
232,1,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
233,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
234,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
235,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
235,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
236,1,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
236,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
236,3,Mucosal ulceration,Mucosal findings abnormal,General system disorders NEC,Genrl,N
237,1,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
237,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
237,3,Mucosal ulceration,Mucosal findings abnormal,General system disorders NEC,Genrl,N
238,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
238,2,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
239,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
239,2,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
239,3,Hemiplegic migraine,Migraine headaches,Headaches,Nerv,N
239,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
240,1,Embolism venous,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
240,2,Left ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
241,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
241,2,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
242,1,Monoclonal immunoglobulin present,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
242,2,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
243,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
243,2,Hyperviscosity syndrome,Haematological disorders,Haematological disorders NEC,Blood,N
244,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
245,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
246,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
247,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
248,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
248,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
248,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
248,4,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
249,1,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,Y
249,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
250,1,Blood product transfusion dependent,Disability issues,Lifestyle issues,SocCi,N
250,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
251,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
251,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
252,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
253,1,Plasma cell leukaemia,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
254,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
255,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
255,2,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,Y
256,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
256,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
256,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
256,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
256,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
256,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
256,7,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
256,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
257,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
257,2,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
258,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
259,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
260,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
260,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
261,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
262,1,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
263,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
264,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
264,2,Gastrointestinal angiodysplasia,Gastrointestinal vascular malformations,Gastrointestinal vascular conditions,Gastr,N
264,3,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
265,1,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
265,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
265,3,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
265,4,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
266,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
266,2,Myopathy,Myopathies,Muscle disorders,Musc,N
267,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
267,2,Myopathy,Myopathies,Muscle disorders,Musc,N
268,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
269,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
270,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
271,1,Deafness,Hearing losses,Hearing disorders,Ear,N
272,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
272,2,Hemianopia homonymous,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
272,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
273,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
273,2,Hemianopia homonymous,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
273,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
274,1,End stage renal disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
275,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
275,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
275,3,Headache,Headaches NEC,Headaches,Nerv,N
276,1,Encephalitis herpes,Herpes viral infections,Viral infectious disorders,Infec,N
276,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
276,3,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
277,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
278,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
278,2,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
278,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
279,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
280,1,Plasma cell leukaemia,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
280,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
280,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
281,1,Adrenocortical carcinoma,Adrenal neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,Y
282,1,Adrenocortical carcinoma,Adrenal neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,Y
282,2,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
282,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
283,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
284,1,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
285,1,Anuria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
285,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
285,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
285,4,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
285,5,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
286,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
286,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
286,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
287,1,Pregnancy of partner,Family and partner issues,Family issues,SocCi,N
288,1,Arteriospasm coronary,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
288,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
288,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
288,4,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
289,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
289,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
289,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
290,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
290,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
290,3,Lung opacity,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
290,4,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
291,1,Embolism venous,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
292,1,Lung squamous cell carcinoma stage III,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
292,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
292,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
292,4,Streptococcal bacteraemia,Streptococcal infections,Bacterial infectious disorders,Infec,N
293,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
294,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
295,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
295,2,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
296,1,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
297,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
298,1,Sarcoma of skin,Soft tissue sarcomas histology unspecified,Soft tissue neoplasms malignant and unspecified,Neopl,N
299,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
300,1,Graves' disease,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
300,2,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
301,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
302,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
302,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
302,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
302,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
302,5,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
302,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
302,7,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
303,1,Graves' disease,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
303,2,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
304,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
304,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
304,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
304,4,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
305,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
306,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
306,2,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
307,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
307,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
307,3,Wheelchair user,Disability issues,Lifestyle issues,SocCi,N
308,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
309,1,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
309,2,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
310,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
310,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
311,1,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
311,2,Strongyloidiasis,Nematode infections,Helminthic disorders,Infec,N
312,1,Chronic graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
312,2,Joint range of motion decreased,Joint related signs and symptoms,Joint disorders,Musc,N
312,3,Restrictive pulmonary disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
312,4,Scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
313,1,Chillblains,Conditions caused by cold,Injuries by physical agents,Inj&P,N
313,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
314,1,Duodenal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
314,2,Strongyloidiasis,Nematode infections,Helminthic disorders,Infec,N
315,1,Duodenal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
315,2,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
316,1,Embolism venous,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,Y
317,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
317,2,Pathological fracture,Fractures NEC,Fractures,Musc,N
318,1,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
319,1,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
320,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
320,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
321,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
321,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
322,1,Metastases to skin,Metastases to specified sites,Metastases,Neopl,Y
323,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
323,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
324,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
325,1,Strongyloidiasis,Nematode infections,Helminthic disorders,Infec,N
326,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
326,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
327,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
327,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
328,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
329,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
329,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
330,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
331,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
332,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
332,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
332,3,Major depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
333,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
334,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
334,2,Gravitational oedema,Oedema NEC,General system disorders NEC,Genrl,N
334,3,Headache,Headaches NEC,Headaches,Nerv,N
334,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
335,1,Duodenal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
335,2,Strongyloidiasis,Nematode infections,Helminthic disorders,Infec,N
336,1,Atrial tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
336,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
336,3,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
337,1,Pathological fracture,Fractures NEC,Fractures,Musc,N
338,1,Chillblains,Conditions caused by cold,Injuries by physical agents,Inj&P,N
338,2,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,N
338,3,Monoclonal immunoglobulin present,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
338,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
338,5,Palpable purpura,Skin vasculitides,Skin vascular abnormalities,Skin,N
338,6,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
338,7,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
338,8,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
338,9,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
338,10,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
339,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
339,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
339,3,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
340,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
341,1,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
341,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
342,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
342,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
342,3,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
342,4,Light chain analysis increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
342,5,Pneumonia klebsiella,Klebsiella infections,Bacterial infectious disorders,Infec,N
343,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
344,1,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
345,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
345,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
345,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
346,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
347,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
347,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
347,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
348,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
348,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
348,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
349,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
349,2,Embolism venous,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,Y
349,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
349,4,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
350,1,Diverticular perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
350,2,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
351,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
351,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
351,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
352,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
352,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
353,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
354,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
355,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
355,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
356,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
357,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
357,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
358,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
358,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
359,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
359,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
359,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
359,4,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
360,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
360,2,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
361,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
362,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
362,2,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
362,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
363,1,Exposed bone in jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
363,2,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
364,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
365,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
365,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
366,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
367,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
367,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
367,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
367,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
368,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
368,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
368,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
368,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
368,5,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
368,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
369,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
369,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
369,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
369,4,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
369,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
369,6,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
369,7,Creatinine renal clearance decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
369,8,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
369,9,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
369,10,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
369,11,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
369,12,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
369,13,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
369,14,Joint effusion,Joint related signs and symptoms,Joint disorders,Musc,N
369,15,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
369,16,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
369,17,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
369,18,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
370,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
370,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
371,1,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
371,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
372,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
373,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
373,2,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
374,1,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
375,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
376,1,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
377,1,Laryngo-onycho-cutaneous syndrome,Laryngeal and tracheal disorders congenital,Respiratory disorders congenital,Cong,N
377,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
377,3,Ovarian failure,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
378,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
379,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
379,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
379,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
379,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
380,1,Chronic graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
381,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
381,2,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
381,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
382,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
383,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
384,1,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
384,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
385,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
386,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
387,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
387,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
388,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
388,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
388,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
389,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
390,1,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
391,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
391,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
391,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
392,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
392,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
392,3,Renal cancer metastatic,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,Y
392,4,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
393,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
393,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
394,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
394,2,Non-cardiac chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
395,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
395,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
395,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
396,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
396,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
396,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
396,4,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
396,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
396,6,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
396,7,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
396,8,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
396,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
396,10,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
396,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
396,12,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
396,13,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
397,1,Bundle branch block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
397,2,Cardiogenic shock,Heart failures NEC,Heart failures,Card,N
397,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
397,4,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,Y
397,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
398,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
398,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
398,3,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
398,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
398,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
399,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
399,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
400,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
400,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
401,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
402,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
403,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
404,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
404,2,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
405,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
406,1,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
406,2,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
406,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
406,4,Idiosyncratic drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
407,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
407,2,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
407,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
408,1,Acute interstitial pneumonitis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
408,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
409,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
409,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
410,1,Arteriovenous fistula thrombosis,Cardiac and vascular procedural complications,Procedural related injuries and complications NEC,Inj&P,N
410,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
410,3,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
411,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
411,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
412,1,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
413,1,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
414,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
415,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
415,2,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
415,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
415,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
416,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
417,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
418,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
419,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
420,1,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
420,2,Headache,Headaches NEC,Headaches,Nerv,N
420,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
420,4,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
421,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
421,2,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
422,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
422,2,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
423,1,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
423,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
424,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
424,2,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
425,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
426,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
426,2,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
427,1,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
427,2,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
427,3,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
428,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
428,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
429,1,Bedridden,Disability issues,Lifestyle issues,SocCi,N
429,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
429,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
429,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
429,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
429,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
429,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
429,8,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
429,9,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
430,1,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
430,2,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
430,3,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
431,1,Blood electrolytes increased,Water and electrolyte analyses NEC,"Water, electrolyte and mineral investigations",Inv,N
431,2,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
431,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
432,1,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
432,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
433,1,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
434,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
435,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
436,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
436,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
437,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
438,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
439,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
439,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
439,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
439,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
439,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
439,6,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
439,7,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
439,8,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
440,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
440,2,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
441,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
441,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
441,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
441,4,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
441,5,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
441,6,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
442,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
442,2,Clavicle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
442,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
442,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
442,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
442,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
442,7,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
442,8,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
443,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
444,1,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
444,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
444,3,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
444,4,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
444,5,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
444,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
444,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
444,8,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
445,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
446,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
447,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
447,2,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
447,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
447,4,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
447,5,Tuberculosis of central nervous system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
448,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
448,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
448,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
449,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
450,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
451,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
452,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
453,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
454,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
455,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
456,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
456,2,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
456,3,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
457,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
457,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
458,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
458,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
458,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
458,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
458,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
459,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
460,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
461,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
461,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
461,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
461,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
461,5,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
462,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
463,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
464,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
464,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
464,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
464,4,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
464,5,Myopathy,Myopathies,Muscle disorders,Musc,N
464,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
464,7,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
465,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
466,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
467,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
468,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
469,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
469,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
469,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
470,1,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
470,2,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
470,3,Growth retardation,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
470,4,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
470,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
470,6,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
470,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
470,8,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
471,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
472,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
472,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
472,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
472,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
472,5,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
472,6,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
472,7,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
472,8,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
472,9,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
473,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
473,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
474,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
474,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
474,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
475,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
476,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
477,1,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
477,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
478,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
479,1,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
479,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
480,1,Electrocardiogram ST-T segment abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
480,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
481,1,Pneumonia influenzal,Influenza viral infections,Viral infectious disorders,Infec,N
481,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
482,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
483,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
484,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
484,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
484,3,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
485,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
486,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
487,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
488,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
488,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
488,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
489,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
489,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
489,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
490,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
490,2,Cardiac failure acute,Heart failures NEC,Heart failures,Card,N
491,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
492,1,Pseudolymphoma,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
493,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
494,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
494,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
495,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
496,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
497,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
498,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
499,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
499,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
499,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
500,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
501,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
501,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
502,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
502,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
502,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
503,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
503,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
503,3,Xerosis,General signs and symptoms NEC,General system disorders NEC,Genrl,N
504,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
505,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
505,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
506,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
507,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
508,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
509,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
509,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
509,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
509,4,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
510,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
510,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
511,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
512,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
512,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
512,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
513,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
514,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
515,1,Embolism venous,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
516,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
517,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
518,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
518,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
519,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
520,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
520,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
520,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
521,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
521,2,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
521,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
522,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
523,1,Behcet's syndrome,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
523,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
523,3,Near death experience,Perception disturbances NEC,Disturbances in thinking and perception,Psych,N
523,4,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
523,5,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
524,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
525,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
525,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
525,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
526,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
526,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
526,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
527,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
528,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
528,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
528,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
528,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
529,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
529,2,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
529,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
529,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
529,5,Reflux laryngitis,Laryngeal and adjacent sites disorders NEC (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
529,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
530,1,Axonal neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
531,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
532,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
533,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
533,2,Diverticulum,Diverticula,Diverticular disorders,Gastr,N
533,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
534,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
535,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
536,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
537,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
537,2,Hospice care,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
537,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
537,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
537,5,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
537,6,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
538,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
538,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
539,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
539,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
539,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
539,4,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
540,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
540,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
540,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
540,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
541,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
541,2,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
541,3,Glucose urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
541,4,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
541,5,Male reproductive tract disorder,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
541,6,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
541,7,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
542,1,Cauda equina syndrome,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
542,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
543,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
543,2,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
543,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
543,4,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
543,5,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
543,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
543,7,Tuberculosis of central nervous system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
544,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
544,2,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
544,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
544,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
544,5,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
544,6,Tuberculosis of central nervous system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
545,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
546,1,Fistula,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
547,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,Y
547,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
547,3,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
547,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
547,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
547,6,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
547,7,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
547,8,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
547,9,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
547,10,Thalamic infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
547,11,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
547,12,Tuberculosis of central nervous system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
547,13,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
548,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
549,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
550,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
550,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
550,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
550,4,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
551,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
551,2,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
551,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
552,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
553,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
553,2,Pseudomyopia,Refractive and accommodative disorders,Vision disorders,Eye,N
554,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
554,2,Underweight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
555,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
556,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
557,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
557,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
557,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
558,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
558,2,Exposure via body fluid,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
558,3,Pregnancy with contraceptive device,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
559,1,Acute abdomen,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
559,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
559,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
559,4,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
559,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
560,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
561,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
562,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
563,1,Red blood cell agglutination,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
564,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
564,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
564,3,Alopecia,Alopecias,Skin appendage conditions,Skin,N
564,4,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
564,5,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
564,6,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
564,7,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
564,8,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
564,9,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
564,10,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
564,11,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
564,12,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
564,13,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
564,14,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
564,15,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
564,16,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
565,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
565,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
565,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
565,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
565,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
566,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
566,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
566,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
566,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
566,5,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
567,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
567,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
567,3,Oral infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
567,4,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
568,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
569,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
570,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
570,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
570,3,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
570,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
570,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
571,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
571,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
571,3,Lymphocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
571,4,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
571,5,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
572,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
572,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
572,3,Intentional self-injury,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
572,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
572,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
572,6,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
573,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
573,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
573,3,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
574,1,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
575,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
575,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
576,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
577,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
577,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
578,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
578,2,Limb reduction defect,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
579,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
580,1,Sickle cell anaemia with crisis,Sickle cell trait and disorders,Haemoglobinopathies,Blood,N
581,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
582,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
583,1,Nerve conduction studies abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
583,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
584,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
584,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
584,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
585,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
586,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
586,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
587,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
588,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
588,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
589,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
589,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
589,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
590,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
590,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
591,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
591,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
592,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
593,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
593,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
